Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 26, 2026
DataAggregated Company Financials
Companies7
- 7D-3.3%
- 3M-8.2%
- 1Y-45.3%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 3.3%, driven by a pullback from Oxford Nanopore Technologies of 4.0%. Meanwhile, hVIVO actually outperformed within the industry, gaining 12% in the last week. The industry has fallen 45% in the last year. Earnings are forecast to grow by 51% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 26 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1126x | -7.6x | 3.9x |
| Tue, 23 Jun 2026 | UK£1.3b | UK£323.0m | -UK£166,018,254.00 | 1296.2x | -8x | 4.1x |
| Thu, 21 May 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.5x | 4.5x |
| Sat, 18 Apr 2026 | UK£1.5b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.8x | 4.6x |
| Mon, 16 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.3x | -8.4x | 4.2x |
| Wed, 11 Feb 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 9.1x | -10.3x | 5.4x |
| Fri, 09 Jan 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 7.8x | -9.9x | 5.2x |
| Sun, 07 Dec 2025 | UK£1.4b | UK£304.3m | -UK£160,776,254.00 | 6.4x | -8.7x | 4.6x |
| Tue, 04 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 8.4x | -9.4x | 5x |
| Thu, 02 Oct 2025 | UK£1.8b | UK£304.0m | -UK£163,375,352.00 | 10x | -10.7x | 5.8x |
| Sat, 30 Aug 2025 | UK£2.0b | UK£291.9m | -UK£160,968,352.00 | 6.3x | -12.2x | 6.7x |
| Mon, 28 Jul 2025 | UK£2.2b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -13.9x | 7.7x |
| Wed, 25 Jun 2025 | UK£1.6b | UK£319.3m | -UK£190,623,734.20 | 6.8x | -8.2x | 4.9x |
| Fri, 23 May 2025 | UK£1.6b | UK£319.7m | -UK£191,086,767.40 | 10.8x | -8.6x | 5.2x |
| Sun, 20 Apr 2025 | UK£1.6b | UK£314.9m | -UK£185,639,007.85 | 6.3x | -8.5x | 5x |
| Tue, 18 Mar 2025 | UK£1.6b | UK£315.5m | -UK£186,056,796.05 | 6.1x | -8.4x | 5x |
| Thu, 13 Feb 2025 | UK£1.9b | UK£307.0m | -UK£195,562,873.68 | 7.1x | -9.6x | 6.1x |
| Sat, 11 Jan 2025 | UK£1.9b | UK£307.6m | -UK£196,106,060.88 | 7.1x | -9.7x | 6.2x |
| Mon, 09 Dec 2024 | UK£2.0b | UK£306.1m | -UK£194,895,325.20 | 8.2x | -10.3x | 6.5x |
| Wed, 06 Nov 2024 | UK£2.0b | UK£304.5m | -UK£192,427,065.70 | 10.9x | -10.3x | 6.5x |
| Fri, 04 Oct 2024 | UK£2.1b | UK£304.3m | -UK£192,233,617.90 | 10.8x | -10.8x | 6.8x |
| Sun, 01 Sep 2024 | UK£1.8b | UK£295.7m | -UK£188,377,847.70 | 12.4x | -9.5x | 6.1x |
| Tue, 30 Jul 2024 | UK£1.8b | UK£295.4m | -UK£189,821,420.43 | 12.7x | -9.7x | 6.2x |
| Thu, 27 Jun 2024 | UK£1.4b | UK£296.0m | -UK£190,362,246.36 | 11.4x | -7.6x | 4.9x |
| Sat, 25 May 2024 | UK£1.7b | UK£295.6m | -UK£189,818,792.31 | 11.3x | -8.7x | 5.6x |
| Mon, 22 Apr 2024 | UK£1.5b | UK£318.0m | -UK£178,762,280.21 | 11.3x | -8.1x | 4.6x |
| Wed, 20 Mar 2024 | UK£1.9b | UK£295.7m | -UK£212,989,389.61 | 7178.2x | -8.8x | 6.3x |
| Fri, 16 Feb 2024 | UK£2.1b | UK£286.0m | -UK£189,380,965.76 | 6963.7x | -10.9x | 7.2x |
| Sun, 14 Jan 2024 | UK£2.9b | UK£449.9m | -UK£173,931,009.00 | 67.7x | -16.9x | 6.5x |
| Tue, 12 Dec 2023 | UK£3.0b | UK£453.0m | -UK£170,801,951.00 | 47x | -17.4x | 6.6x |
| Thu, 09 Nov 2023 | UK£3.1b | UK£458.3m | -UK£165,340,179.00 | 47.3x | -18.8x | 6.8x |
| Sat, 07 Oct 2023 | UK£2.9b | UK£458.4m | -UK£165,438,742.00 | 54.3x | -17.6x | 6.3x |
| Mon, 04 Sep 2023 | UK£3.1b | UK£476.5m | -UK£126,789,628.00 | 70.6x | -24.6x | 6.5x |
| Wed, 02 Aug 2023 | UK£3.4b | UK£476.5m | -UK£124,693,730.00 | 69.6x | -27.1x | 7.1x |
Price to Earnings Ratio
-27.1x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 3.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.20% | |
| Healthcare | 0.051% | |
| Life Sciences | -3.33% | |
| Clinical Research and Equipment | -3.33% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HVO hVIVO | UK£0.075 | 11.9% +UK£5.5m | -25.0% | PS1x | |
| FAB Fusion Antibodies | UK£0.11 | 4.4% +UK£562.6k | 22.9% | PS8.4x |